Home 
Endocrine Regulations 2008 Endocrine Regulations Vol.42, p.63-68, 2008
Endocrine Regulations 2008 Endocrine Regulations Vol.42, p.63-68, 2008
Journal info
|
||
Select Journal
Journals
Bratislava Medical Journal Endocrine Regulations 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 General Physiology and Biophysics Neoplasma Acta Virologica Studia Psychologica Cardiology Letters Psychológia a patopsych. dieťaťa Kovove Materialy-Metallic Materials Slovenská hudbaWebshop Cart
Your Cart is currently empty.
Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.
Endocrine Regulations Vol.42, p.63-68, 2008 |
||
| Title: INVERSE RELATIONSHIP BETWEEN ADIPONECTIN AND PLASMINOGEN ACTIVATOR INHIBITOR-1 IN METABOLIC SYNDROME PATIENTS | ||
| Author: S. BILGILI, A. C. CELEBILER, A. DOGAN, B. KARACA | ||
| Abstract: Objectivs. To determine the serum levels of adiponectin and plasminogen activator inhibitor-1 in metabolic syndrome versus healthy controls and to see the relation of them with each other and with the metabolic syndrome components. Methods. Adiponectin and plasminogen activator inhibitor-1 levels were measured in 53 subjects with metabolic syndrome and 30 healthy controls by ELISA. All subjects of metabolic syndrome had the criterias of metabolic syndrome (obesity, insulin resistance, hypertension, dyslipidemia, glucose metabolism disorders). Adiponectin and plasminogen activator inhibitor-1 levels in serum were compared between the groups and relations of them with each other, with metabolic syndrome components, also HbA1c and C peptidewere examined. For statistical analysis studentt test and pearson’s correlations were used. Results. Metabolic syndrome group had significantly lower adiponectin and higher plasminogen activator inhibitor-1 levels than healthy controls (p-1 may be useful for management of the metabolic syndrome so this may prevent the development of obesity, cardiovascular diseases and diabetes. |
||
| Keywords: Metabolic syndrome – Adiponectin - Plasminogen activator inhibitor-1.- Obesity | ||
| Year: 2008, Volume: 42, Issue: 2 | Page From: 63, Page To: 68 | |
|
|
 download file |
|